Background & Aims:
On-going risk behaviour can lead to hepatitis C virus (HCV) reinfection
following successful treatment. We aimed to assess the incidence of
persistent HCV reinfection in a population of people who inject drugs
(PWID) who had achieved sustained virological response (SVR) seven years
earlier.
Methods: In 2004–2006 we conducted a multicentre treatment trial comprising HCV genotype 2 or 3 patients in Sweden, Norway and Denmark (NORTH-C). Six months of abstinence from injecting drug use (IDU) was required before treatment. All Norwegian patients who had obtained SVR (n = 161) were eligible for participation in this long-term follow-up study assessing virological and behavioural characteristics.
Results: Follow-up data were available in 138 of 161 (86%) individuals. Persistent reinfection was identified in 10 ...
SunnyPharma.org and SoulofHealing.orgMethods: In 2004–2006 we conducted a multicentre treatment trial comprising HCV genotype 2 or 3 patients in Sweden, Norway and Denmark (NORTH-C). Six months of abstinence from injecting drug use (IDU) was required before treatment. All Norwegian patients who had obtained SVR (n = 161) were eligible for participation in this long-term follow-up study assessing virological and behavioural characteristics.
Results: Follow-up data were available in 138 of 161 (86%) individuals. Persistent reinfection was identified in 10 ...
No comments:
Post a Comment